| 1st Nov 2019 9:53 am |
RNS |
Total Voting Rights |
| 31st Oct 2019 1:34 pm |
RNS |
Director/PDMR Shareholding |
| 30th Oct 2019 5:32 pm |
RNS |
Director/PDMR Shareholding |
| 30th Oct 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 30th Oct 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 30th Oct 2019 12:00 pm |
RNS |
3rd Quarter Results |
| 21st Oct 2019 8:00 am |
RNS |
GSK divests two travel vaccines to Bavarian Nordic |
| 15th Oct 2019 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Oct 2019 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Oct 2019 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Oct 2019 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 11th Oct 2019 5:34 pm |
RNS |
Director/PDMR Shareholding |
| 11th Oct 2019 4:10 pm |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2019 4:18 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2019 6:18 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2019 1:09 pm |
RNS |
Total Voting Rights |
| 30th Sep 2019 7:00 am |
RNS |
PRIMA shows Zejula improves PFS in ovarian cancer |
| 30th Sep 2019 7:00 am |
RNS |
Data show anti-tumour activity with ICOS agonist |
| 26th Sep 2019 6:26 pm |
RNS |
Director/PDMR Shareholding |
| 17th Sep 2019 5:46 pm |
RNS |
Director/PDMR Shareholding |
| 11th Sep 2019 4:30 pm |
RNS |
Director/PDMR Shareholding |
| 4th Sep 2019 5:37 pm |
RNS |
Director/PDMR Shareholding |
| 4th Sep 2019 12:36 pm |
RNS |
Director/PDMR Shareholding |
| 4th Sep 2019 9:33 am |
RNS |
Director/PDMR Shareholding |
| 2nd Sep 2019 11:29 am |
RNS |
Total Voting Rights |
| 23rd Aug 2019 7:00 am |
RNS |
GSK - positive results from pivotal DREAMM-2 study |
| 22nd Aug 2019 7:00 am |
RNS |
ViiV results positive for every 2 month injection |
| 21st Aug 2019 8:00 am |
RNS |
GSK submits regulatory file in Japan: Daprodustat |
| 12th Aug 2019 3:45 pm |
RNS |
Director/PDMR Shareholding |
| 1st Aug 2019 3:30 pm |
RNS |
EU approval for Nucala self-administration |
| 1st Aug 2019 2:10 pm |
RNS |
Total Voting Rights |
| 1st Aug 2019 7:00 am |
RNS |
GSK completes transaction with Pfizer for New JV |
| 30th Jul 2019 3:35 pm |
RNS |
Director/PDMR Shareholding |
| 29th Jul 2019 7:00 am |
RNS |
ViiV submits cabotegravir to EMA for HIV injection |
| 24th Jul 2019 6:01 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jul 2019 4:01 pm |
RNS |
ViiV 2DR TANGO switch study positive at 48 weeks |
| 24th Jul 2019 4:00 pm |
RNS |
ViiV GEMINI studies show high efficacy at 96 weeks |
| 24th Jul 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 24th Jul 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 24th Jul 2019 12:00 pm |
RNS |
2nd Quarter Results |
